Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 316,995 |
|
|||||
| News | - | ||||||
| Day High | 0.5017 | Low High |
|||||
| Day Low | 0.4789 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| BioVie Inc | BIVI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0011 | 0.22% | 0.49 | 19:44:02 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.4809 | 0.4789 | 0.5017 | 0.4848 | 0.4889 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,252 | 316,995 | $ 0.487988 | $ 154,690 | - | 0.445 - 8.69 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:44:01 | formt | 100 | $ 0.49 | USD |
BioVie Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 19.54M | 39.87M | - | 0 | -50.26M | -1.26 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
BioVie News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BIVI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.505 | 0.524 | 0.462 | 0.4926868 | 667,905 | -0.015 | -2.97% |
| 1 Month | 0.5286 | 0.561 | 0.445 | 0.4926239 | 840,221 | -0.0386 | -7.30% |
| 3 Months | 1.04 | 3.31 | 0.445 | 1.40 | 2,794,361 | -0.55 | -52.88% |
| 6 Months | 3.04 | 5.82 | 0.445 | 1.66 | 1,690,280 | -2.55 | -83.88% |
| 1 Year | 7.13 | 8.69 | 0.445 | 2.03 | 961,955 | -6.64 | -93.13% |
| 3 Years | 18.75 | 23.86 | 0.445 | 3.79 | 506,504 | -18.26 | -97.39% |
| 5 Years | 10.50 | 46.0977 | 0.445 | 4.31 | 435,328 | -10.01 | -95.33% |
BioVie Description
| BioVie Inc is a company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is currently focused on developing and commercializing BIV201, a novel investigational approach to the treatment of ascites due to chronic liver cirrhosis. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism. |
